- Home
- ACCO vs EBS Comparison
ACCO vs EBS Comparison
Compare ACCO & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACCO
- EBS
- Stock Information
- Founded
- ACCO 1893
- EBS 1998
- Country
- ACCO United States
- EBS United States
- Employees
- ACCO N/A
- EBS N/A
- Industry
- ACCO Publishing
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- ACCO Consumer Discretionary
- EBS Health Care
- Exchange
- ACCO Nasdaq
- EBS Nasdaq
- Market Cap
- ACCO 356.9M
- EBS 423.6M
- IPO Year
- ACCO N/A
- EBS 2006
- Fundamental
- Price
- ACCO $4.13
- EBS $9.14
- Analyst Decision
- ACCO Buy
- EBS Strong Buy
- Analyst Count
- ACCO 1
- EBS 2
- Target Price
- ACCO $6.00
- EBS $13.50
- AVG Volume (30 Days)
- ACCO 590.5K
- EBS 959.0K
- Earning Date
- ACCO 10-30-2025
- EBS 11-05-2025
- Dividend Yield
- ACCO 7.26%
- EBS N/A
- EPS Growth
- ACCO N/A
- EBS N/A
- EPS
- ACCO 0.49
- EBS 2.53
- Revenue
- ACCO $1,581,200,000.00
- EBS $851,600,000.00
- Revenue This Year
- ACCO N/A
- EBS N/A
- Revenue Next Year
- ACCO $2.11
- EBS $19.24
- P/E Ratio
- ACCO $8.43
- EBS $3.62
- Revenue Growth
- ACCO N/A
- EBS N/A
- 52 Week Low
- ACCO $3.32
- EBS $4.02
- 52 Week High
- ACCO $6.44
- EBS $12.73
- Technical
- Relative Strength Index (RSI)
- ACCO 57.67
- EBS 65.40
- Support Level
- ACCO $4.03
- EBS $8.58
- Resistance Level
- ACCO $4.10
- EBS $9.34
- Average True Range (ATR)
- ACCO 0.11
- EBS 0.38
- MACD
- ACCO -0.01
- EBS 0.10
- Stochastic Oscillator
- ACCO 53.45
- EBS 85.94
About ACCO Acco Brands Corporation
ACCO Brands Corp designs, manufactures, and markets consumer and business products. It operates through two segments: ACCO Brands Americas, and ACCO Brands International. The company offers school notebooks, janitorial supplies, and whiteboards; storage and organization products, sheet protectors, and indexes, and punching products; computer accessories and others used in schools, homes, and businesses. The company markets and sells its products through various channels, including mass retailers; e-tailers; discount, and variety chains; and warehouse clubs. It generates maximum profit from ACCO Brands America segment.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.